Robert Doebele - 31 Mar 2022 Form 4 Insider Report for Rain Therapeutics Inc.

Signature
/s/ Nelson Cabatuan, Attorney-in-fact for Robert Doebele
Issuer symbol
N/A
Transactions as of
31 Mar 2022
Net transactions value
+$7,900
Form type
4
Filing time
04 Apr 2022, 16:15:31 UTC
Previous filing
04 Feb 2022
Next filing
15 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RAIN Common Stock Options Exercise $7,900 +2,000 +0.43% $3.95 469,937 31 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Options Exercise $0 -2,000 -14% $0.000000 11,890 31 Mar 2022 Common Stock 2,000 $3.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 13,890 shares of Issuer's common stock, which is vested in full.

Remarks:

President, Chief Scientific Officer